Two Very Different Approaches
Sclerotherapy involves injecting a chemical agent (liquid or foam) directly into a vein, causing endothelial damage, thrombosis, and eventual fibrosis. VenaBlock® delivers cyanoacrylate adhesive that mechanically seals the vein wall without causing endothelial chemical destruction.
Both are minimally invasive, office-based procedures — but they have very different indications, efficacy profiles, and limitations.
Where Sclerotherapy Excels
Sclerotherapy remains the preferred treatment for:
- Small-diameter superficial varicosities (<3 mm)
- Spider veins and telangiectasias (liquid sclerotherapy)
- Residual tributary veins following truncal ablation
- Perforator vein incompetence (ultrasound-guided foam)
The Limitation of Sclerotherapy for Truncal Reflux
When applied to large-diameter truncal veins (GSV, SSV), sclerotherapy — even in foam form — produces significantly lower and less durable closure rates compared to endovenous thermal ablation or VenaBlock®. The dynamic blood flow in large saphenous veins rapidly dilutes the sclerosant before adequate wall contact is achieved.
Published 5-year data shows foam sclerotherapy GSV closure rates of 40–60% — far below the 91.1% at 5 years reported for VenaBlock®.
Side Effect Profiles
Sclerotherapy carries specific risks that VenaBlock® does not:
- Visual disturbances and migraine: Associated with foam sclerotherapy, likely due to microbubble embolization through patent foramen ovale
- Matting: Formation of new fine vessel networks around injected sites
- Hyperpigmentation: Brown skin staining along treated veins, more common with larger vein sclerotherapy
- Cutaneous necrosis: If sclerosant extravasates into surrounding tissue
The Complementary Relationship
In clinical practice, VenaBlock® and sclerotherapy are often used together: VenaBlock® ablates the incompetent saphenous trunk, eliminating the source of reflux, followed by ultrasound-guided foam sclerotherapy to treat residual tributary varicosities. This combination approach maximizes efficacy while minimizing invasiveness.